文献速递造血干细胞移植与细胞治疗

T细胞受损及「记忆样」NK细胞重建与来特莫韦停药后迟发性HCMV再激活相关

Impaired T cells and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation.
PubMed 文献 · Blood Adv · 2024-01-01

研究纳入24例异基因造血干细胞移植受者,在来特莫韦停药前(+90天)及停药后(+120至+270天)共7个时间点检测NK细胞及HCMV pp65特异性T细胞重建。发生临床显著HCMV感染(csCMVi)者HCMV特异性CD4+和CD8+ T细胞计数较低,且「记忆样」CD159c+CD56dim NK细胞减少先于csCMVi事件;HCMV特异性T细胞和「记忆样」NK细胞最少者HCMV表现最重。

要点

  • 来特莫韦停药后发生csCMVi者HCMV特异性CD4+和CD8+ T细胞计数低于HCMV控制者
  • csCMVi患者「记忆样」CD159c+CD56dim NK细胞减少,且多数先于csCMVi事件出现
  • HCMV终末器官病和/或难治性感染者HCMV特异性T细胞及「记忆样」NK细胞最少

核心结论

  • HCMV特异性T细胞和「记忆样」NK细胞增殖延迟或不足与来特莫韦停药后csCMVi及HCMV表现严重程度相关。

研究设计与样本

  • 研究纳入24例异基因造血干细胞移植受者,在来特莫韦停药前(+90天)及停药后(+120至+270天)共7个时间点检测NK细胞重建及整体和HCMV pp65特异性T细胞库。

主要发现

  • 发生csCMVi者HCMV特异性IFN-γ+ CD4+和CD8+ T细胞计数低于HCMV控制者。
  • csCMVi患者NK细胞重建延迟受损,尤以「记忆样」CD159c+CD56dim NK细胞计数受抑,且多数患者该抑制先于csCMVi事件。
  • HCMV终末器官病和/或难治性HCMV感染者HCMV特异性T细胞和「记忆样」NK细胞最少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Allogeneic hematopoietic stem cell transplantation (alloSCT) is the only cure for many hematologic malignancies. However, alloSCT recipients are susceptible to opportunistic pathogens, such as human cytomegalovirus (HCMV). Letermovir prophylaxis has revolutionized HCMV management, but the challenge of late HCMV reactivations has emerged. Immunological surrogates of clinically significant HCMV infection (csCMVi) after discontinuation of letermovir remain to be defined. Therefore, we studied natural killer (NK)-cell reconstitution along with the global and HCMV pp65-specific T-cell repertoire of 24 alloSCT recipients at 7 time points before (day +90) and after (days +120-270) cessation of letermovir prophylaxis. Patients who experienced csCMVi had lower counts of IFN-γ+ HCMV-specific CD4+ and CD8+ T cells than HCMV controllers. Furthermore, patients with csCMVi displayed late impairment of NK-cell reconstitution, especially suppression of "memory-like" CD159c+CD56dim NK-cell counts that preceded csCMVi events in most patients. Moreover, several surrogates of immune reconstitution were associated with the severity of HCMV manifestation, with patients suffering from HCMV end-organ disease and/or refractory HCMV infection harboring least HCMV-specific T cells and "memory-like" NK cells. Altogether, our findings establish an association of delayed or insufficient proliferation of both HCMV-specific T cells and "memory-like" NK cells with csCMVi and the severity of HCMV manifestations after discontinuation of letermovir prophylaxis.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lauruschkat CD, Muchsin I, Rein AF, et al. Impaired T cells and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation. Blood Adv. 2024. PMID: 38315873. doi:10.1182/bloodadvances.2023012008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。